{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:05Z","timestamp":1793371025219,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020642","name":"Balnaves Foundation Pty Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.09.105","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:39:58Z","timestamp":1790869198000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early use of mepolizumab in Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: A prospective multicenter, open-label, pilot study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-5663","authenticated-orcid":false,"given":"James","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Katelaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Zubrinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie W.Y.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2026.09.105_bib1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.09.105_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaip.2017.10.020","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome successfully treated with mepolizumab","volume":"6","author":"Ange","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2026.09.105_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40629-022-00224-7","article-title":"Treatment with IL5-\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"32","author":"Gschwend","year":"2023","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaad.2026.09.105_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1134178","article-title":"Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"14","author":"Rubin","year":"2023","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.jaad.2026.09.105_bib5","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.3390\/jcm11226642","article-title":"Off-label benralizumab in severe non-necrotizing eosinophilic vasculitis following critical COVID-19 disease and in DRESS","volume":"11","author":"Pintea","year":"2022","journal-title":"J Clin Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222603656X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222603656X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:19Z","timestamp":1793370499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222603656X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":5,"alternative-id":["S019096222603656X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.105","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early use of mepolizumab in Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: A prospective multicenter, open-label, pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}